Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONCURRENT TECHNOLOGIES PLC Regulatory Filings 2023

Nov 8, 2023

7571_rns_2023-11-08_45390676-335b-45cd-91ab-fd8e1c64e17b.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 6973S

Concurrent Technologies PLC

08 November 2023

08 November 2023

Concurrent Technologies Plc

(the 'Company')

Change of Nominated Adviser

Concurrent Technologies (AIM: CNC), the market leading specialists in the design, development, and manufacture of deployable embedded computer solutions for critical applications, announces that, following the completion of the all-share merger between Cavendish Securities plc (previously named Cenkos Securities plc) and Cavendish Financial plc (previously named finnCap Group plc), and as a consequence of internal reorganisation within the Cavendish Group, the Company has changed its Nominated Adviser and Broker from Cavendish Securities plc to Cavendish Capital Markets Limited.

Enquiries:

Concurrent Technologies Plc

Miles Adcock - CEO

Kim Garrod - CFO
+44 (0)1206 752626
SEC Newgate (Financial PR)

Bob Huxford

Alice Cho

Matthew Elliott
[email protected]

07469 154806
Cavendish Capital Markets Limited (NOMAD)

Neil McDonald

Peter Lynch
+44 (0)131 220 9771

+44 (0)131 220 9772

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

APPFSAFWWEDSEFF